合計 50 件の最近のインサイダー取引記録が記録されています Karuna Therapeutics, Inc. (KRTX), 内訳は 16 件の買い および 32 件の売り. インサイダー買い総額は $16.89M インサイダー売り総額は $49.48M.
最近活動のある主要インサイダーには Jonas Jeffrey M, Coughlin Christopher J, Paul Steven M. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — KRTX
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2024-03-18 |
Jonas Jeffrey M |
Director |
株式返還 |
1,904 |
$237.70 |
$452.58K |
- |
| 2024-03-18 |
Coughlin Christopher J |
Director |
株式返還 |
1,904 |
$237.70 |
$452.58K |
- |
| 2024-03-18 |
Paul Steven M |
Director |
株式返還 |
135,992 |
$99.72 |
$13.56M |
- |
| 2024-03-18 |
Healy James |
Director |
株式返還 |
1,904 |
$237.70 |
$452.58K |
- |
| 2024-03-18 |
Meury William |
President and CEO |
株式返還 |
63,065 |
$193.19 |
$12.18M |
- |
| 2024-03-18 |
Olson Laurie J |
Director |
株式返還 |
1,904 |
$237.70 |
$452.58K |
- |
| 2024-03-18 |
Pande Atul |
Director |
株式返還 |
1,904 |
$237.70 |
$452.58K |
- |
| 2024-03-18 |
Brannan Stephen K. |
Chief Medical Officer |
株式返還 |
17,350 |
$187.26 |
$3.25M |
- |
| 2024-03-18 |
Miller Andrew Craig |
President of R&d |
株式返還 |
9,412 |
$330.00 |
$3.11M |
- |
| 2024-03-18 |
Wheadon David E. |
Director |
株式返還 |
1,904 |
$237.70 |
$452.58K |
- |
| 2024-03-18 |
Kane William P Jr |
Chief Commercial Officer |
株式返還 |
29,937 |
$192.15 |
$5.75M |
- |
| 2024-03-18 |
Torres Denice |
Director |
株式返還 |
1,904 |
$237.70 |
$452.58K |
- |
| 2024-03-18 |
Brown Jason Parker |
Chief Financial Officer |
株式返還 |
7,696 |
$169.09 |
$1.3M |
- |
| 2024-03-08 |
Brannan Stephen K. |
Chief Medical Officer |
オプション行使（売却） |
2,500 |
$5.45 |
$13.63K |
4,677 |
| 2024-03-04 |
Paul Steven M |
Director |
贈与（送付） |
30,304 |
- |
- |
2,364 |
| 2024-03-01 |
Paul Steven M |
Director |
贈与（送付） |
30,304 |
- |
- |
10,000 |
| 2024-02-29 |
Paul Steven M |
Director |
その他（買い） |
47,378 |
$315.18 |
$14.93M |
70,608 |
| 2024-02-23 |
Paul Steven M |
Director |
オプション行使 |
27,510 |
$7.27 |
$200K |
38,106 |
| 2024-02-13 |
Meury William |
President and CEO |
RSU 付与（制限付株式） |
38,688 |
- |
- |
38,688 |
| 2024-02-13 |
Brannan Stephen K. |
Chief Medical Officer |
RSU 付与（制限付株式） |
10,306 |
- |
- |
10,306 |
| 2024-02-13 |
Miller Andrew Craig |
President of R&d |
RSU 付与（制限付株式） |
15,855 |
- |
- |
15,855 |
| 2024-02-13 |
Kane William P Jr |
Chief Commercial Officer |
RSU 付与（制限付株式） |
10,306 |
- |
- |
10,306 |
| 2024-02-13 |
Brown Jason Parker |
Chief Financial Officer |
RSU 付与（制限付株式） |
10,306 |
- |
- |
10,306 |
| 2024-02-09 |
Paul Steven M |
Director |
RSU 源泉徴収 |
804 |
$317.14 |
$254.98K |
10,596 |
| 2024-02-09 |
Brannan Stephen K. |
Chief Medical Officer |
RSU 源泉徴収 |
1,046 |
$317.14 |
$331.73K |
40,104 |
| 2024-02-09 |
Miller Andrew Craig |
President of R&d |
RSU 源泉徴収 |
1,011 |
$317.14 |
$320.63K |
23,389 |
| 2024-02-08 |
Brannan Stephen K. |
Chief Medical Officer |
オプション行使（売却） |
2,500 |
$5.45 |
$13.63K |
7,177 |
| 2024-01-08 |
Brannan Stephen K. |
Chief Medical Officer |
オプション行使（売却） |
2,500 |
$5.45 |
$13.63K |
9,677 |
| 2023-12-28 |
Meury William |
President and CEO |
RSU 源泉徴収 |
8,694 |
$316.30 |
$2.75M |
29,379 |
| 2023-12-28 |
Kane William P Jr |
Chief Commercial Officer |
RSU 源泉徴収 |
3,828 |
$316.30 |
$1.21M |
13,828 |
| 2023-12-08 |
Brannan Stephen K. |
Chief Medical Officer |
オプション行使（売却） |
2,500 |
$5.45 |
$13.63K |
12,177 |
| 2023-11-08 |
Brannan Stephen K. |
Chief Medical Officer |
オプション行使（売却） |
2,500 |
$5.45 |
$13.63K |
14,677 |
| 2023-10-09 |
Brannan Stephen K. |
Chief Medical Officer |
オプション行使（売却） |
2,500 |
$5.45 |
$13.63K |
17,177 |
| 2023-09-29 |
Brown Jason Parker |
Chief Financial Officer |
処分 |
7,100 |
$191.79 |
$1.36M |
- |
| 2023-09-29 |
Brown Jason Parker |
Chief Financial Officer |
RSU 付与（制限付株式） |
7,696 |
$169.09 |
$1.3M |
7,696 |
| 2023-09-08 |
Brannan Stephen K. |
Chief Medical Officer |
オプション行使（売却） |
2,500 |
$5.45 |
$13.63K |
19,677 |
| 2023-09-01 |
Jonas Jeffrey M |
Director |
情報に基づく売り |
399 |
$188.98 |
$75.4K |
990 |
| 2023-08-22 |
Ignelzi Troy A. |
Chief Financial Officer |
情報に基づく売り |
60 |
$176.60 |
$10.6K |
30,487 |
| 2023-08-08 |
Brannan Stephen K. |
Chief Medical Officer |
オプション行使（売却） |
2,500 |
$5.45 |
$13.63K |
22,177 |
| 2023-08-01 |
Jonas Jeffrey M |
Director |
情報に基づく売り |
600 |
$198.41 |
$119.05K |
990 |
| 2023-07-03 |
Jonas Jeffrey M |
Director |
情報に基づく売り |
2,409 |
$217.82 |
$524.73K |
990 |
| 2023-07-03 |
Olson Laurie J |
Director |
情報に基づく売り |
400 |
$216.03 |
$86.41K |
990 |
| 2023-06-20 |
Jonas Jeffrey M |
Director |
RSU 付与（制限付株式） |
990 |
- |
- |
990 |
| 2023-06-20 |
Coughlin Christopher J |
Director |
RSU 付与（制限付株式） |
990 |
- |
- |
990 |
| 2023-06-20 |
Healy James |
Director |
RSU 付与（制限付株式） |
1,904 |
$237.70 |
$452.58K |
1,904 |
| 2023-06-20 |
Olson Laurie J |
Director |
RSU 付与（制限付株式） |
990 |
- |
- |
990 |
| 2023-06-20 |
Pande Atul |
Director |
RSU 付与（制限付株式） |
990 |
- |
- |
990 |
| 2023-06-20 |
Wheadon David E. |
Director |
RSU 付与（制限付株式） |
990 |
- |
- |
990 |
| 2023-06-20 |
Torres Denice |
Director |
RSU 付与（制限付株式） |
990 |
- |
- |
990 |
| 2023-06-14 |
Healy James |
Director |
その他（買い） |
8,025 |
- |
- |
8,025 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
